BioPlus Acquisition Corp. (NASDAQ:BIOS) Shares Acquired by Marshall Wace LLP

Marshall Wace LLP grew its position in BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) by 31.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 502,350 shares of the company’s stock after acquiring an additional 120,000 shares during the period. Marshall Wace LLP’s holdings in BioPlus Acquisition were worth $5,049,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of BIOS. Goldman Sachs Group Inc. acquired a new position in shares of BioPlus Acquisition in the first quarter worth about $8,152,000. Polar Asset Management Partners Inc. acquired a new position in shares of BioPlus Acquisition during the 1st quarter worth about $7,410,000. Starboard Value LP acquired a new position in shares of BioPlus Acquisition during the 1st quarter worth about $6,098,000. Spring Creek Capital LLC acquired a new position in shares of BioPlus Acquisition during the 1st quarter worth about $4,940,000. Finally, Radcliffe Capital Management L.P. acquired a new position in shares of BioPlus Acquisition during the 1st quarter worth about $3,953,000. Institutional investors and hedge funds own 72.81% of the company’s stock.

BioPlus Acquisition Stock Performance

BIOS opened at $10.40 on Tuesday. BioPlus Acquisition Corp. has a twelve month low of $9.85 and a twelve month high of $10.43. The company has a 50-day moving average price of $10.33 and a 200 day moving average price of $10.19.

BioPlus Acquisition Company Profile

(Get Rating)

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.